IRIDEX Corp
NASDAQ:IRIX
IRIDEX Corp
Other Current Liabilities
IRIDEX Corp
Other Current Liabilities Peer Comparison
Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Other Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
IRIDEX Corp
NASDAQ:IRIX
|
Other Current Liabilities
$4m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
18%
|
CAGR 10-Years
14%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Other Current Liabilities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Boston Scientific Corp
NYSE:BSX
|
Other Current Liabilities
$956m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
2%
|
CAGR 10-Years
12%
|
|
Stryker Corp
NYSE:SYK
|
Other Current Liabilities
$749m
|
CAGR 3-Years
15%
|
CAGR 5-Years
16%
|
CAGR 10-Years
12%
|
|
Abbott Laboratories
NYSE:ABT
|
Other Current Liabilities
$1.5B
|
CAGR 3-Years
12%
|
CAGR 5-Years
13%
|
CAGR 10-Years
3%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Other Current Liabilities
$489.3m
|
CAGR 3-Years
6%
|
CAGR 5-Years
9%
|
CAGR 10-Years
8%
|
See Also
What is IRIDEX Corp's Other Current Liabilities?
Other Current Liabilities
4m
USD
Based on the financial report for Mar 30, 2024, IRIDEX Corp's Other Current Liabilities amounts to 4m USD.
What is IRIDEX Corp's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 10Y
14%
Over the last year, the Other Current Liabilities growth was 17%. The average annual Other Current Liabilities growth rates for IRIDEX Corp have been -1% over the past three years , 18% over the past five years , and 14% over the past ten years .